Prime Therapeutics Files Data Breach Report in Illinois

Prime Therapeutics, a company that manages prescription drug benefits, officially reported a data security incident to the Illinois Attorney General on March 20, 2026. This public filing indicates that unauthorized parties gained access to some of the company's internal systems. The investigation into the full scope of this incident is currently ongoing.

While specific categories of information were not detailed in the public filing, the nature of Prime Therapeutics' operations means they handle sensitive personal information. If you received a formal notification letter from Prime Therapeutics, it confirms that your personal or health-related information may have been involved in this event.

Individuals who receive a data breach notification should carefully read the letter for specific instructions and details relevant to their situation. It is always prudent to monitor your accounts and statements for any unusual activity.

Consider placing a fraud alert or security freeze on your credit reports with the three major credit bureaus. Be cautious of unsolicited communications, as scammers may try to exploit data breaches by impersonating affected organizations. Report any suspicious activity to the appropriate authorities.

This information is based on the official data breach filing made by Prime Therapeutics with the Illinois Attorney General's office. This public record serves to inform potentially affected individuals and the public about the incident.